Kinesiotaping in Isolated Meniscus Injuries
The Effect of Kinesiotaping on Pain and Functionality in Isolated Meniscus Injuries: A Randomized Controlled Study
Bandırma Onyedi Eylül University
75 participants
Apr 1, 2026
INTERVENTIONAL
Conditions
Summary
The effect of kinesiotaping on pain and functionality in isolated meniscus injuries.
Eligibility
Inclusion Criteria6
- Ages 18-50
- Knee pain lasting longer than 2 weeks
- Having a diagnosis of isolated meniscus injury (grade 1, 2 or 3 meniscus degeneration) confirmed by magnetic resonance imaging (MRI)
- Not having undergone knee surgery in the last 6 months
- Not having received intraarticular injections in the knee area
- Being willing to participate in the study
Exclusion Criteria10
- Trauma history
- Anterior or posterior cruciate ligament injury
- Collateral ligament injuries
- Advanced knee osteoarthritis
- Rheumatic or neurological disease
- Allergy or skin condition to kinesiotape
- History of intraarticular injection
- Neuromuscular dysfunction
- Rheumatological disease
- Cognitive dysfunction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
sham taping will be applied three times, once every five days. the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
rengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification.
Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07574307